Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Total article views   HTML views PDF downloads Totals
9,777 Dovepress* 8,907+ 1,280 10,187
PubMed Central* 870 270 1,140
Totals 9,777 1,550 11,327
*Since 5 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar